Xing Yuan Selected Research

DNA (Deoxyribonucleic Acid)

1/2017	Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
1/2016	Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer.
7/2007	[Surgical correction of male external genitalia giant condyloma acuminata].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xing Yuan Research Topics

Disease

13	Neoplasms (Cancer) 04/2024 - 11/2002
6	Hepatocellular Carcinoma (Hepatoma) 04/2018 - 11/2013
5	Tuberculosis (Tuberculoses) 11/2019 - 07/2014
4	Infections 11/2019 - 03/2010
3	Cognitive Dysfunction 01/2023 - 03/2016
3	Breast Neoplasms (Breast Cancer) 12/2022 - 10/2014
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2020
3	Wounds and Injuries (Trauma) 01/2018 - 07/2007
2	Pain (Aches) 08/2023 - 09/2022
2	Brain Ischemia (Cerebral Ischemia) 03/2018 - 05/2012
2	Ischemic Stroke 03/2018 - 05/2012
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2018 - 01/2016
2	Extensively Drug-Resistant Tuberculosis 01/2017 - 01/2017
2	Pheochromocytoma 03/2015 - 05/2012
2	Carcinoma (Carcinomatosis) 10/2014 - 04/2014
1	Dehydration (Water Stress) 04/2023
1	Poisoning 01/2023
1	Triple Negative Breast Neoplasms 12/2022
1	Ulcerative Colitis 09/2022
1	Drug Resistant Epilepsy 01/2022
1	Dysbiosis 01/2021
1	Hand-Foot Syndrome 09/2020
1	Exanthema (Rash) 09/2020
1	Pruritus (Itching) 09/2020
1	Ascites 01/2020
1	Proteinuria 11/2019
1	Atrophy 11/2019
1	Body Weight (Weight, Body) 11/2019
1	Extrapulmonary Tuberculosis 11/2019
1	Epilepsy (Aura) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Cough 01/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Purpura 01/2019
1	Headache (Headaches) 01/2019
1	Liver Neoplasms (Liver Cancer) 04/2018
1	Brain Infarction 03/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2018
1	Brain Edema (Cerebral Edema) 03/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Myocardial Infarction 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2018
3	bacopaside IIBA 01/2023 - 03/2016
3	Amyloid (Amyloid Fibrils)IBA 01/2023 - 03/2016
3	Immune Checkpoint InhibitorsIBA 12/2022 - 09/2020
3	CytokinesIBA 09/2022 - 07/2014
3	LipidsIBA 11/2019 - 11/2002
3	CateninsIBA 01/2018 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 07/2007
2	Peptides (Polypeptides)IBA 01/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2019
2	SantoninIBA 04/2018 - 01/2017
2	XanthineIBA 04/2018 - 12/2016
2	GuanineIBA 04/2018 - 12/2016
2	Therapeutic UsesIBA 10/2017 - 03/2016
2	Kanamycin FDA Link 01/2017 - 01/2017
2	Amikacin (A.M.K)FDA LinkGeneric 01/2017 - 01/2017
2	FluoroquinolonesIBA 01/2017 - 01/2017
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2017 - 01/2017
2	Neuroprotective AgentsIBA 03/2016 - 05/2012
2	OligodeoxyribonucleotidesIBA 03/2004 - 11/2002
2	Folic Acid (Vitamin M)FDA LinkGeneric 03/2004 - 11/2002
1	pentabromodiphenyl ether (PBDE)IBA 04/2024
1	ChitosanIBA 08/2023
1	CarbonIBA 04/2023
1	VanadiumIBA 01/2023
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2023
1	chlorobenzeneIBA 01/2023
1	Mitochondrial DNA (mtDNA)IBA 09/2022
1	glycyrrhizae radix et rhizomaIBA 09/2022
1	Proteolysis Targeting ChimeraIBA 01/2022
1	cupric sulfide (CuS)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2020
1	Alanine Transaminase (SGPT)IBA 09/2020
1	NivolumabIBA 09/2020
1	pembrolizumabIBA 09/2020
1	apatinibIBA 09/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	bilobetinIBA 11/2019
1	Inflammation MediatorsIBA 11/2019
1	purineIBA 01/2019
1	NucleotidesIBA 01/2019
1	perampanelIBA 03/2018
1	Ionotropic Glutamate ReceptorsIBA 03/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018
1	STA 9090IBA 01/2018
1	tanespimycin (17AAG)IBA 01/2018
1	nitazoxanide (NTZ)FDA Link 01/2018

Therapy/Procedure

4	Therapeutics 12/2022 - 07/2014
4	Drug Therapy (Chemotherapy) 12/2022 - 07/2014
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2022 - 03/2015
2	Immunotherapy 12/2022 - 01/2022
1	Radiotherapy 12/2022
1	Oncolytic Virotherapy 12/2022
1	Vagus Nerve Stimulation 01/2022
1	Neoadjuvant Therapy 05/2021
1	Intraperitoneal Injections 11/2019
1	Oral Administration 03/2018